Colon Cancer Clinical Trials 2024

What are the top hospitals conducting colon cancer research?

In the fight against colon cancer, several hospitals have emerged as leaders in conducting clinical trials that aim to improve treatment and outcomes for patients. One such institution is Alta Bates Summit Medical Center-Herrick Campus located in Berkeley, California. With four active colon cancer trials currently underway and a total of six completed studies dedicated to this condition, the hospital has been actively involved in research since recording its first trial in 2005. Similarly, Contra Costa Regional Medical Center in Martinez has also made significant contributions with four ongoing colon cancer trials and a notable history of eleven previously conducted studies dating back to their initial trial in 2004.

Moving further south to Modesto, Memorial Medical Center continues to play an important role with four active clinical trials focused on colon cancer and eight successful previous investigations since their inaugural study commenced in 2004. Likewise, Palo Alto Medical Foundation-Camino Division situated in Mountain View has established itself as another key player by conducting four ongoing colon cancer trials alongside seven accomplished ones that date back seventeen years ago when they initiated their groundbreaking investigation on this condition.

Notably contributing towards advancements within the field is Sutter Roseville Medical Center positioned at Roseville; In addition holding up through it's current participation within same number of concurrent examinations are eight earlier inquiries revolving around Colon Cancer which stretches out from past seventeen years commencing initially during year 2004.Its lasting presence atop these statistics proves how diligently each facility works toward understanding and combating this disease - ultimately leading us closer to better treatments for those affected by colon cancer.

These hospitals serve as beacons of hope for individuals facing colon cancer diagnosis across various locations while reflecting how medical professionals work tirelessly toward improving patient care through scientific exploration

Which are the best cities for colon cancer clinical trials?

When it comes to clinical trials for colon cancer, several cities emerge as top contenders. Denver, Colorado leads with 19 active trials focusing on treatments like celecoxib, Fluorouracil, and Atezolizumab. Los Angeles, California follows closely with 16 ongoing studies examining interventions such as Atezolizumab and celecoxib. Anchorage, Alaska also shows promise with 15 active trials investigating treatment options including Subprotocol C2 (MET exon 14 deletion/mutation), celecoxib, and Fluorouracil. These cities offer individuals battling colon cancer access to cutting-edge research that may pave the way for improved outcomes in their fight against the disease.

Which are the top treatments for colon cancer being explored in clinical trials?

Colon cancer research is constantly evolving, and in recent clinical trials, two treatments have emerged as promising contenders. Dostarlimab has shown potential with one active trial dedicated to colon cancer. It joined the scene in 2023 and has already accumulated a total of two clinical trials for this specific type of cancer. Another intriguing approach being explored is aerobic exercise, which also boasts one active trial and two all-time colon cancer trials since its first listing in 2023. These innovative treatments offer hope for improved outcomes in fighting this formidable disease by combining medical advancements with lifestyle interventions.

What are the most recent clinical trials for colon cancer?

Exciting advancements are being made in the field of colon cancer research through recent clinical trials. One notable trial focuses on neoadjuvant therapy, which aims to improve treatment outcomes by administering therapies before surgery. Another study is evaluating the efficacy of dostarlimab, a potential breakthrough immunotherapy option for colon cancer patients. Additionally, two different arms of a trial are investigating the effectiveness of encorafenib and cetuximab combination therapy as well as fentanyl citrate and propofol anesthesia in colon cancer treatment. By exploring these innovative approaches, researchers hope to enhance therapeutic options and provide better outcomes for individuals battling colon cancer.

What colon cancer clinical trials were recently completed?

Recently, several clinical trials investigating treatments for colon cancer have reached completion, reflecting the relentless efforts of researchers in this field. In January 2022, Mayo Clinic successfully concluded a trial examining the Colorectal cancer Peptide Vaccine PolyPEPI1018. Mirati Therapeutics Inc.'s investigation into MRTX849 also wrapped up in August 2021. While George E. Peoples' PalloV-CC study reached its conclusion in July 2019, Mayo Clinic's examination of American Ginseng completed in March 2019 and Asha Nayak's pembrolizumab trial finalized in January 2018. Furthermore, both Academic and Community Cancer Research United and Wake Forest University Health Sciences conducted studies that ended earlier; the former's Pharmacological Study was completed in March 2015 while the latter's exploration of 6,8-bis(benzylthio)octanoic acid finished their research project in January 2015.